Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avax Technologies Inc.
DescriptionHapten-modified autologous ovarian tumor cell vaccine
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationOvarian cancer
Indication DetailsTreat advanced ovarian cancer following chemotherapy; Treat ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today